US 12371498 — Patent Expiration

NOVEL COMBINATION AND USE OF ANTIBODIES

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US12371498

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn how PTE is calculated

US 12371498

Novel Combination And Use Of Antibodies

High Confidence

Application No. 16959425

September 3, 2042

16y 14d remaining

Could not fetch continuity data for application PCTEP2019050566: Resource not found (404)

Earliest effective filing

Jan 10, 2019

+ 20 years

Jan 10, 2039

PTA +1332d

Sep 3, 2042

No TD

—

Final

Sep 3, 2042

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation Details

Base Term Calculation

Filing Date

June 30, 2020

Earliest Effective Filing

January 10, 2019

Issue Date

July 29, 2025

PTA

+1332 days

Base Expiry (before PTA)

January 10, 2039

January 10, 2019 + 20 years = January 10, 2039 + 1332 PTA days = September 3, 2042

National Stage Entry of application PCTEP2019050566, filed Jan 10, 2019

Terminal Disclaimer Analysis

No TD

0 approved, 0 filed

Who owns this patent?

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.